Chronic granulocytic leukemia can be relieved mainly by targeted therapy, there is a possibility of relapse, but the chance of relapse can not be determined, and the disease factors, the effect of treatment, as well as living environment and other factors.
Chronic granulocytic leukemia is a malignant tumor disease, generally difficult to completely cure, but most patients can achieve long-term survival through timely targeted therapy. Generally speaking, there are many targeted therapeutic drugs for this disease, including Dasatinib tablets, Nilotinib capsules and Flumatinib mesylate tablets, etc., so as to control the development of the disease.
This disease does not have a clear probability of recurrence, and can be affected by factors such as disease factors, treatment effects, and improper care. Generally speaking, after targeted therapy, although one’s condition has been alleviated, there may still be some abnormal leukemia cells. Once the medication is stopped, then it will easily lead to a relapse of the disease.
If the patient does not follow the doctor’s instructions to take medication, change or stop taking medication at will, then the chance of relapse will also increase. In addition, if the patient does not pay attention to care, often exposed to a variety of harmful chemicals, such as formaldehyde, etc., then over time, it is very likely to lead to a relapse of the disease.
Therefore, patients should actively cooperate with the doctor’s treatment, and strengthen the daily care, eat more fresh vegetables and fruits, eat less spicy and stimulating food, rest more, keep enough sleep, so as to avoid deterioration of the condition, and then relapse. The use of drugs should be under the guidance of a physician.